Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts. Show More...
-
Website https://www.biogen.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 113.60 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 3.94 5.04 5.76 7.81 12.37 15.34 16.93 11.92 21.58 31.42 32.35 Dividends USD Payout Ratio % * Shares Mil 255.0 245.0 240.0 238.0 237.0 231.0 219.0 213.0 205.0 187.0 181.0 Book Value Per Share * EUR 15.82 19.86 21.25 25.0 36.58 44.27 53.09 50.93 61.08 71.86 69.11 Free Cash Flow Per Share * EUR 3.68 4.59 4.84 -4.64 9.07 11.86 14.04 10.55 20.39 29.59 Return on Assets % 12.08 14.4 14.39 16.94 22.42 20.97 17.47 10.91 18.11 22.42 22.37 Financial Leverage (Average) 1.5 1.41 1.46 1.38 1.32 2.08 1.88 1.88 1.94 2.04 2.08 Return on Equity % 17.31 20.88 20.62 23.9 30.21 35.15 34.42 20.52 34.54 44.64 44.58 Return on Invested Capital % 14.59 17.67 17.77 21.71 28.6 26.4 22.28 14.2 23.97 29.59 29.24 Interest Coverage 35.07 52.85 51.82 78.76 134.78 50.92 19.97 21.45 30.41 39.03 38.9 Current Ratio 2.42 3.26 1.96 1.81 2.11 2.6 2.55 2.34 2.32 1.72 1.73 Quick Ratio 1.95 2.74 1.61 1.31 1.54 1.93 1.94 1.78 1.83 1.43 1.39 Debt/Equity 0.2 0.17 0.1 0.07 0.05 0.7 0.54 0.47 0.46 0.37 0.39